The epidemiology of candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: Follow-up to a randomized clinical trial

Annals of Surgery

Volumn 249, Issue 4, 2009, Pages 657-665

  Magill, Shelley S ^a,d   Swoboda, Sandra M ^a   Shields, Christine E ^a   Colantuoni, Elizabeth A ^b   Fothergill, Annette W ^c   Merz, William G ^a   Lipsett, Pamela A ^a   Hendrix, Craig W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ANTIFUNGAL AGENT;

ADULT; AGED; ARTICLE; CANDIDA; CANDIDA GLABRATA; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FUNGAL COLONIZATION; FUNGUS CULTURE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; BACTERIAL COUNT; COMPARATIVE STUDY; CROSS INFECTION; DRUG EFFECT; FOLLOW UP; FUNGEMIA; HOSPITALIZATION; INCIDENCE; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PREOPERATIVE CARE; PROSPECTIVE STUDY; RISK; RISK ASSESSMENT; STATISTICAL MODEL; SURGERY; SURVIVAL RATE; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA GLABRATA; CANDIDIASIS; COLONY COUNT, MICROBIAL; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; FLUCONAZOLE; FOLLOW-UP STUDIES; FUNGEMIA; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 65449172069     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31819ed914     Document Type: Article

References (39)

1. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309-317.
2. Morgan J, Meltzer MI, Plikaytis BD, et al. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol. 2005;26:540-547.
3. Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosoco-mial candidemia, revisited. Clin Infect Dis. 2003;37:1172-1177.
4. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med. 1992;326:845-851.
5. Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study. J Infect Dis. 1995;171:1545-1552.
6. Marr KA, Seidel K, Slavin MA, et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood. 2000;96:2055-2061.
7. Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis. 2001;33:177-186.
8. Pelz RK, Lipsett PA, Swoboda SM, et al. The diagnostic value of fungal surveillance cultures in critically ill patients. Surg Infect. 2000;1:273-281.
9. Pittet D, Monod M, Suter PM, et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994;220:751-758.
10. Borzotta AP, Beardsley K. Candida infections in critically ill trauma patients: a retrospective case-control study. Arch Surg. 1999;134:657-665.
11. Pelz RK, Hendrix CW, Swoboda SM, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg. 2001;233:542-548.
12. Eggimann P, Francioli P, Bille J, et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med. 1999;27:1066-1072.
13. Garbino J, Lew DP, Romand JA, et al. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med. 2002;28:1708-1717.
14. Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care unit patients: a systematic review and meta-analysis. Intensive Care Med. 2005;31:1479-1487.
15. Playford EG, Webster AC, Sorrell TC, et al. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother. 2006;57:628-638.
16. Shorr AF, Chung K, Jackson WL, et al. Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med. 2005;33:1928-1935.
17. Vardakas KZ, Samonis G, Michalopoulos A, et al. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med. 2006;34:1216-1224.
18. Marr KA, Seidel K, White TC, et al. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis. 2000;181:309-316.
19. Bodey GP, Mardani M, Hanna HA, et al. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med. 2002;112:380-385.
20. Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med. 1991;325:1274-1277.
21. Wingard JR, Merz WG, Rinaldi MG, et al. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother. 1993;37:1847-1849.
22. Abi-Said D, Anaissie E, Uzon O, et al. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis. 1997;24: 1122-1128.
23. Vos MC, Endtz HP, Horst-Kreft D, et al. Candida krusei transmission among hematology patients resolved by adapted antifungal prophylaxis and infection control measures. J Clin Microbiol. 2006;44:1111-1114.
24. Arendrup MA, Fuursted K, Gahrn-Hansen B, et al. Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol. 2005;43:4434-4440.
25. Pfaller MA, Diekema DJ, Rinaldi MJ, et al. Results from the ARTEMIS DISK global antifungal surveillance study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol. 2005;43:5848-5859.
26. Sandven P, Bevanger L, Digranes A, et al. Candidemia in Norway (1991 to 2003): results from a nationwide survey. J Clin Microbiol. 2006;44:1977-1981.
27. Baddley JW, Smith AM, Moser SA, et al. Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a university hospital. Diagn Microbiol Infect Dis. 2001;39:199-201.
28. Puzniak L, Teutsch S, Powderly W, et al. Has the epidemiology of nosocomial candidemia changed? Infect Control Hosp Epidemiol. 2004;25:628-633.
29. Malani A, Hmoud J, Chiu L, et al. Candida glabrata fungemia: experience in a tertiary care center. Clin Infect Dis. 2005;41:975-981.
30. Swoboda SM, Merz WG, Lipsetta PA. Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit. Surg Infect (Larchmt). 2003;4: 345-354.
31. American College of Chest Physicians/Society of Critical Care Medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
32. Magill SS, Swoboda SM, Johnson EA, et al. The association between anatomic site of Candida colonization, invasive candidiasis and mortality in critically ill surgical patients [Erratum in: Diagn Microbiol Infect Dis. 2007;57:351]. Diagn Microbiol Infect Dis. 2006;55:293-301.
33. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M27-A2. National Committee for Clinical Laboratory Standards: Wayne, PA; 2002.
34. Pelz RK. Nosocomial Candida Infections in High-Risk Critically Ill Patients: Diagnosis, Cost, and Prevention [dissertation]. Baltimore, MD: Johns Hopkins University; 2000.
35. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34: 7-14.
36. Rosenbaum P, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
37. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757-763.
38. Dykewicz CA; Centers for Disease Control and Prevention (US); Infectious Diseases Society of America; American Society of Blood and Marrow Transplantation. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis. 2001;33:139-144.
39. Manzoni P, Arisio R, Mostert M, et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infection in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics. 2006;117:22-32.